Raimund Strehl new CTO of NovaHep AB

PRESS RELEASE

June 10, 2015

 

Dr. Raimund Strehl will assume the position as Chief Technology Officer at NovaHep AB, starting August 1, 2015.

“We are very pleased to announce that Raimund Strehl will be joining our team. With an impressive network and extensive experience within the industry of stem cells and regenerative medicine, Raimund will be a key person in NovaHep’s continued efforts on the path towards providing a range of personalised tissues and organs for reconstructive surgery. Relying on comprehensive competencies within process development and industrialisation of regenerative medicine, Raimund has taken several stem cell products to market. He will be instrumental in realising our tissue-engineered veins as our targeted first application”, says NovaHep CEO Petter Björquist.

NovaHep AB is a Gothenburg-based Swedish regenerative medicine company with a unique technology for developing a broad range of biocompatible tissues and organs. NovaHep is addressing the major shortcomings and drawbacks associated with organ transplantation of today, such as a lack of suitable organs available, the adverse side-effects of immunosuppressive drugs, and the oftentimes need for repeated surgery. Objectives are to provide for improved quality of life for patients worldwide, and cost-effective care for hospitals, healthcare-providers and society. NovaHep’s products in development rely on patient-individualisation of donated organs and tissues by applying advanced, proprietary stem cell technology. NovaHep has shown proof-of-concept with successful transplantations carried out at Sahlgrenska University Hospital in 2011 and 2012.

For further information, please contact Petter Björquist at petter.bjorquist@novahep.com or call +46 705 979296.